When did MADRIGAL PHARMACEUTICALS INC (1MDGL.MI) report earnings last quarter?
MADRIGAL PHARMACEUTICALS INC (1MDGL.MI) last reported earnings on 11/4/2025.
MADRIGAL PHARMACEUTICALS INC (1MDGL.MI) Earnings History & Surprises
BIT:1MDGL • US5588681057
Current stock price
412.7 EUR
+33.3 (+8.78%)
Last:
1MDGL.MI Earnings overview
Past quarterly earnings results for MADRIGAL PHARMACEUTICALS INC (1MDGL.MI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Feb 19, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.92
- Revenue Estimate
- 318.74M
Last Reported
Most Recent- Release Date
- Nov 4, 2025
- Period
- Q3 / 2025
- EPS Reported
- -$4.96
- EPS Surprise
- -133.61%
- Revenue Surprise
- 13.88%
Beat Rate
Last 8 Quarters 31%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -4.96 | -2.12 | -133.61% | -0.81% | 287.268M | 252.25M | 13.88% | 362.03% |
| Q2 2025 | -1.90 | -3.71 | 48.79% | 73.24% | 212.802M | 165.56M | 28.53% | 1,353.76% |
| Q1 2025 | -3.32 | -3.84 | 13.46% | 55.01% | 137.25M | 116.1M | 18.22% | - |
| Q4 2024 | -2.71 | -4.33 | 37.40% | 52.29% | 103.32M | 100.53M | 2.78% | - |
| Q3 2024 | -4.92 | -7.05 | 30.22% | 7.87% | 62.175M | 34.873M | 78.29% | - |
| Q2 2024 | -7.10 | -7.68 | 7.50% | -51.39% | 14.638M | 3.981M | 267.70% | - |
| Q1 2024 | -7.38 | -6.41 | -15.12% | -74.47% | - | - | ||
| Q4 2023 | -5.68 | -5.39 | -5.38% | -14.06% | - | - | ||
| Q3 2023 | -5.34 | -5.02 | -6.30% | -12.42% | - | - | ||
| Q2 2023 | -4.69 | -4.67 | -0.37% | -13.29% | - | - | ||
| Q1 2023 | -4.23 | -5.04 | 16.00% | -25.89% | - | - | ||
| Q4 2022 | -4.98 | -4.65 | -7.16% | -31.75% | - | - | ||
| Q3 2022 | -4.75 | -4.24 | -12.11% | -25.33% | - | - | ||
| Q2 2022 | -4.14 | -3.77 | -9.78% | -11.29% | - | - | ||
| Q1 2022 | -3.36 | -3.69 | 9.02% | -1.20% | - | - | ||
| Q4 2021 | -3.78 | -3.95 | 4.41% | 1.05% | - | - | ||
| Q3 2021 | -3.79 | -3.98 | 4.67% | -1.07% | - | - | ||
| Q2 2021 | -3.72 | -3.66 | -1.75% | -16.98% | - | - | ||
| Q1 2021 | -3.32 | -3.92 | 15.32% | -41.88% | - | - | ||
| Q4 2020 | -3.82 | -3.93 | 2.85% | - | - | - | ||
| Q3 2020 | -3.75 | -3.36 | -11.47% | - | - | - | ||
| Q2 2020 | -3.18 | -2.50 | -27.07% | - | - | - | ||
| Q1 2020 | -2.34 | -1.98 | -18.07% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
-8.49%
Max EPS beat (4)
48.79%
Min EPS beat (4)
-133.61%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
15.85%
Max Revenue beat (4)
28.53%
Min Revenue beat (4)
2.78%
Analysis
In the last 4 quarters, 1MDGL.MI has beaten EPS estimates in 3 out of 4 releases
1MDGL.MI has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, 1MDGL.MI reported -8.5% below the EPS estimates on average.
In the last 4 quarters, 1MDGL.MI has beaten the revenue estimates by 15.9% on average.
Related analysis
MADRIGAL PHARMACEUTICALS INC / 1MDGL.MI Earnings FAQ
Can you provide information on whether MADRIGAL PHARMACEUTICALS INC beat earnings estimates in the last quarter?
MADRIGAL PHARMACEUTICALS INC (1MDGL.MI) missed EPS estimates and beat revenue estimates in the most recent quarter.
How often does MADRIGAL PHARMACEUTICALS INC (1MDGL.MI) beat earnings estimates?
In the last 4 quarters, MADRIGAL PHARMACEUTICALS INC (1MDGL.MI) has beaten EPS estimates in 3 out of 4 releases.